Tectonic Therapeutic | AVRO - Debt


Tectonic Therapeutic reported $876K in Debt for its fiscal quarter ending in December of 2024.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alnylam Pharmaceuticals USD 1.27B 5.33M Mar/2026
Celltrion KRW 160.58B 733.3M Mar/2026
Cspc Pharmaceutical CNY 641.11M 146.11M Dec/2025
Deva Holding AS TRY 5.3B 871.93M Sep/2023
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
Kangmei Pharma CNY 173.71M 42.08M Mar/2026
Karyopharm Therapeutics USD 299.23M 35.14M Dec/2025
Knight Therapeutics CAD 77.91M 28.33M Dec/2025
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
MacroGenics USD 36.51M 500K Mar/2026
Malin Corporation EUR 100K 0 Dec/2023
Medical Developments International AUD 1.99M 152K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 8.2M 554K Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 63.73B 231M Mar/2026
Pharma Mar EUR 45.84M 1.7M Jun/2026
Qiagen NV USD 1.65B 165.82M Mar/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 23.58B 3.56B Jun/2026
Sarepta Therapeutics USD 1.04B 3.08M Mar/2026
Sartorius EUR 4.05B 248.8M Jun/2026
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Takeda JPY 4.94T 58.13B Jun/2026
Tilray USD 640.95M 35.17M Jun/2022
Zealand Pharma A/S 414M 8.23M Mar/2026
Zz Pientze Pharmaceu CNY 1.07B 2.82M Mar/2026